Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-28

Clinical Trial Update: Eplerenone, ACE Inhibition and Albuminuria [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating eplerenone in combination with ACE inhibition on albuminuria in diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACE inhibitors
  • eplerenone (eplerenone)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED